Comment by
subaru1i on Feb 13, 2024 1:21pm
mdjbrown...go back in time...not that long when LABS announced they developed their own in house CBG....I think Avicanna and LABS hooked up through the expanded strategic manufacturing agreement, including SEDDS technology for TWO MARKETS.....Canada and then with LABS being FDA approved, pending DEA descheduling, AVCN has an open door into the U.S. market.